Robeco Institutional Asset Management B.V. Has $6.52 Million Holdings in Axon Enterprise, Inc $AXON

Robeco Institutional Asset Management B.V. lessened its stake in Axon Enterprise, Inc (NASDAQ:AXON) by 89.7% in the fourth quarter, Holdings Channel reports. The firm owned 11,485 shares of the biotechnology company’s stock after selling 99,712 shares during the quarter. Robeco Institutional Asset Management B.V.’s holdings in Axon Enterprise were worth $6,523,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. Howard Capital Management Inc. raised its stake in Axon Enterprise by 365.9% in the fourth quarter. Howard Capital Management Inc. now owns 2,553 shares of the biotechnology company’s stock valued at $1,450,000 after purchasing an additional 2,005 shares in the last quarter. Massachusetts Financial Services Co. MA raised its stake in Axon Enterprise by 23.0% in the fourth quarter. Massachusetts Financial Services Co. MA now owns 838,289 shares of the biotechnology company’s stock valued at $476,089,000 after purchasing an additional 156,647 shares in the last quarter. Apollon Wealth Management LLC raised its stake in Axon Enterprise by 9.3% in the fourth quarter. Apollon Wealth Management LLC now owns 4,127 shares of the biotechnology company’s stock valued at $2,344,000 after purchasing an additional 351 shares in the last quarter. Spirepoint Private Client LLC raised its stake in Axon Enterprise by 5.3% in the fourth quarter. Spirepoint Private Client LLC now owns 20,295 shares of the biotechnology company’s stock valued at $11,526,000 after purchasing an additional 1,016 shares in the last quarter. Finally, BNC Wealth Management LLC raised its stake in Axon Enterprise by 1.7% in the fourth quarter. BNC Wealth Management LLC now owns 11,058 shares of the biotechnology company’s stock valued at $6,280,000 after purchasing an additional 183 shares in the last quarter. Institutional investors and hedge funds own 79.08% of the company’s stock.

Insider Transactions at Axon Enterprise

In other news, insider Isaiah Fields sold 2,000 shares of the company’s stock in a transaction that occurred on Friday, February 27th. The stock was sold at an average price of $535.01, for a total value of $1,070,020.00. Following the completion of the transaction, the insider owned 55,588 shares of the company’s stock, valued at $29,740,135.88. This represents a 3.47% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Erika Nardini sold 198 shares of the company’s stock in a transaction that occurred on Tuesday, March 17th. The shares were sold at an average price of $506.58, for a total value of $100,302.84. Following the completion of the transaction, the director directly owned 1,946 shares of the company’s stock, valued at $985,804.68. This represents a 9.24% decrease in their position. The SEC filing for this sale provides additional information. In the last three months, insiders have sold 13,855 shares of company stock valued at $7,109,828. 4.40% of the stock is owned by company insiders.

Axon Enterprise Stock Up 5.6%

AXON stock opened at $402.18 on Thursday. The stock has a market capitalization of $32.34 billion, a P/E ratio of 264.59, a price-to-earnings-growth ratio of 8.13 and a beta of 1.61. The company has a current ratio of 2.53, a quick ratio of 2.29 and a debt-to-equity ratio of 0.53. Axon Enterprise, Inc has a 12 month low of $339.01 and a 12 month high of $885.91. The firm has a 50-day moving average price of $460.43 and a 200-day moving average price of $558.53.

Axon Enterprise (NASDAQ:AXON) last posted its earnings results on Tuesday, February 24th. The biotechnology company reported $2.15 EPS for the quarter, topping analysts’ consensus estimates of $1.60 by $0.55. The firm had revenue of $796.72 million during the quarter, compared to analysts’ expectations of $755.29 million. Axon Enterprise had a net margin of 4.48% and a return on equity of 2.82%. The business’s revenue for the quarter was up 38.5% compared to the same quarter last year. During the same quarter in the prior year, the business earned $2.08 earnings per share. As a group, equities research analysts anticipate that Axon Enterprise, Inc will post 5.8 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research firms recently commented on AXON. Barclays dropped their price target on Axon Enterprise from $702.00 to $682.00 and set an “overweight” rating for the company in a research note on Wednesday, February 25th. Weiss Ratings downgraded Axon Enterprise from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Friday, April 10th. Royal Bank Of Canada dropped their target price on shares of Axon Enterprise from $860.00 to $735.00 and set an “outperform” rating for the company in a report on Wednesday, February 25th. Citigroup reissued a “buy” rating on shares of Axon Enterprise in a report on Wednesday, February 25th. Finally, Morgan Stanley reissued an “overweight” rating on shares of Axon Enterprise in a report on Wednesday, April 8th. Sixteen research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, Axon Enterprise presently has a consensus rating of “Moderate Buy” and an average price target of $755.88.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.